These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2993936)

  • 1. Proteolytic activity in brains of rabbits treated with aluminum.
    Benuck M; Iqbal K; Wisniewski HM; Lajtha A
    Neurochem Res; 1985 Jun; 10(6):729-36. PubMed ID: 2993936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of lysosomal enzymes in rabbit brain with experimental neurofibrillary changes.
    Suzuki H; Takeda M; Nakamura Y; Tada K; Hariguchi S; Nishimura T
    Neurosci Lett; 1988 Jun; 89(2):234-9. PubMed ID: 3393297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum chloride induced neurofibrillary changes in the developing rabbit a chronic animal model.
    Wisniewski HM; Sturman JA; Shek JW
    Ann Neurol; 1980 Nov; 8(5):479-90. PubMed ID: 7192069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain.
    Cataldo AM; Nixon RA
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3861-5. PubMed ID: 1692625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolysis in quaking mouse brain and spinal cord.
    McAlhaney WW; Banik NL; Greenfield S; Hogan EL
    Neurochem Res; 1986 Feb; 11(2):173-83. PubMed ID: 3010146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease.
    Nakamura Y; Takeda M; Suzuki H; Hattori H; Tada K; Hariguchi S; Hashimoto S; Nishimura T
    Neurosci Lett; 1991 Sep; 130(2):195-8. PubMed ID: 1795881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic characterization of cathepsin D in rabbit brains with experimental neurofibrillary changes.
    Suzuki H; Takeda M; Nishimura T
    Biochem Mol Biol Int; 1994 Apr; 32(6):1033-9. PubMed ID: 8061619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues.
    Nakanishi H; Tominaga K; Amano T; Hirotsu I; Inoue T; Yamamoto K
    Exp Neurol; 1994 Mar; 126(1):119-28. PubMed ID: 8157122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic model of neurofibrillary changes induced in mature rabbits by metallic aluminum.
    Wisniewski HM; Sturman JA; Shek JW
    Neurobiol Aging; 1982; 3(1):11-22. PubMed ID: 7099362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration.
    Crapper DR; Krishnan SS; Dalton AJ
    Science; 1973 May; 180(4085):511-3. PubMed ID: 4735595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic enzymes in ordinary, hyperacute, monocytic and passive transfer forms of experimental allergic encephalomyelitis.
    Marks N; Grynbaum A; Levine S
    Brain Res; 1977 Mar; 123(1):147-57. PubMed ID: 843913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of cathepsin A and D activities and Ca, Mg, Cu, Zn, Fe, Na and K levels in pig skin as a tool for the differential diagnosis between vital and postmortem skin wounds.
    Hernandez-Cueto C; Luna-Maldonado A; Villanueva Canadas E
    Acta Med Leg Soc (Liege); 1984; 34():174-8. PubMed ID: 6242907
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
    Savory J; Huang Y; Wills MR; Herman MM
    Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits.
    Beal MF; Mazurek MF; Ellison DW; Kowall NW; Solomon PR; Pendlebury WW
    Neuroscience; 1989; 29(2):339-46. PubMed ID: 2566953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal proteinases as putative diagnostic tools in human neuropathology: Alzheimer disease (AD) and schizophrenia.
    Bernstein HG; Kirschke H; Wiederanders B; Khudoerkov RM; Hinz W; Rinne A
    Acta Histochem Suppl; 1992; 42():19-24. PubMed ID: 1584965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain enzymes as receptors: angiotensin-converting enzyme and enkephalin convertase.
    Snyder SH
    Ann N Y Acad Sci; 1986; 463():21-30. PubMed ID: 2424356
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrastructural localization of neurofilament proteins in aluminum-induced neurofibrillary tangles and rat cerebellum by immunoperoxidase labeling.
    Dahl D; Nguyen BT; Bignami A
    Dev Neurosci; 1982; 5(1):54-63. PubMed ID: 7049661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
    Walton JR
    J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of corticosterone binding in vitro, in rabbit hippocampus, by chromatin bound aluminum.
    Sanderson C; McLachlan DR; De Boni U
    Acta Neuropathol; 1982; 57(4):249-54. PubMed ID: 7136502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenylyl cyclase activity in postmortem human brain: evidence of altered G protein mediation in Alzheimer's disease.
    Cowburn RF; O'Neill C; Ravid R; Alafuzoff I; Winblad B; Fowler CJ
    J Neurochem; 1992 Apr; 58(4):1409-19. PubMed ID: 1548475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.